7-Keto® from Humanetics Provides Fat-Burning Efficacy for Dexatrim Max Complex 7™

Humanetics Corporation & Chattem, Inc® recently announced their new partnership with the launch of Dexatrim Max Complex 7, new proprietary blend that combines 7 powerful weight loss ingredients with 7-Keto to increase metabolism and burn fat.

7-Keto (3-acetyl-7-oxo dehydroepiandrosterone) is a naturally occurring substance produced by the body in the adrenal glands and its production declines with age. It is a non-stimulant, thermogenic agent that is clinically proven to increase metabolism and promote healthy weight loss. 7-Keto works naturally with the body to enhance the activity of three thermogenic enzymes – Glycerol-3-phosphate dehydrogenase, Malic Enzyme & Fatty Acyl CoA Oxidase. The up-regulation of these three key fat burning, thermogenic enzymes results in a higher metabolic rate
and clinical studies have shown that administration of 7-Keto increases metabolism by 5.4%1, promotes weight loss without stimulants and produces 3 times more weight loss than diet & exercise alone. Specifically, 7-Keto plus a restricted calorie diet demonstrated an increase in RMR of 1.4% above baseline levels versus a 3.9% decrease in RMR in the restricted calorie diet only group. Two independently conducted clinical trials conducted by Peak Wellness Center and Minnesota Applied Research Center support the effectiveness of 7-Keto for weight loss. Both trials were double-blinded and placebo-controlled, and have been published in peer-reviewed journals. 2, 3

The latest statistics from the National Health and Nutrition Examination Survey 2005-2006 indicate that an estimated 32.7 percent of U.S. adults 20 years and older are overweight, 34.3 percent are obese and 5.9 percent are extremely obese. In addition, overweight and obesity have a significant economic impact on the U.S. health care system, including associated diseases and health conditions such as coronary heart disease, Type 2 diabetes, certain types of cancers, hypertension, stroke and osteoarthritis, to name a few. Further, a recent study in the Annals of Internal Medicine reported that 90% of men and 70% of women will eventually become overweight.

And globally, the World Health Organization predicts that by 2015, there will be more than 1.5 billion overweight consumers, incurring health costs beyond $117 billion per year in the US economy alone.

“Weight loss and weight management continue to be a huge health concern and social issue for American consumers,” says Scott Steil, President, Nutra Bridge. “And manufacturers are still highly interested in the weight loss market given its size and steady performance over the years, with a current market value of $1.8 billion according to Nutrition Business Journal,” says Steil. “Our new partnership with Chattem is a great opportunity for our company and product portfolio given that Dexatrim is such a leader in the weight loss arena. The newly launched Dexatrim Max Complex 7 offers consumers a highly efficacious product backed by solid, published clinical efficacy and safety data. The fact that 7-Keto is a key ingredient in Chattem’s weight loss product line further strengthens it’s position as one of the best weight loss ingredients available to consumers today.”

About Chattem®
Chattem, Inc. was founded as the Chattanooga Medicine Company in 1879 and is a leading marketer and manufacturer of a broad portfolio of branded OTC healthcare products, toiletries and dietary supplements. The company's products target niche market segments and are among the market leaders in their respective categories across food, drug and mass merchandisers. The company's portfolio of products includes well-recognized brands such as Icy Hot, Gold Bond(R), Selsun Blue(R), ACT(R), Cortizone-10(R) and Unisom(R). Chattem conducts a portion of its global business through subsidiaries in the United Kingdom, Ireland and Canada. For more information, visit www.chattem.com.

About Humanetics Corporation
Founded in 1988, Humanetics Corporation is a privately held corporation focused on providing proprietary, sciencebased solutions to consumer health and aging concerns. Humanetics Corporation markets 7-Keto® for weight loss, MicroLactin® for inflammation and joint health and Inzitol™ for glucose transport and creatine uptake by muscle cells. For more information, visit www.humaneticsingredients.com.

About Nutra Bridge
Nutra Bridge, launched in 2008, connects ingredient suppliers to marketers of foods and dietary supplements. The company’s mission is to represent innovative, branded, and patented ingredients that are backed by world-class science supporting efficacy and safety. The exclusive product portfolio of Nutra Bridge includes: 7-Keto® (weight loss), InSea2™ (blood glucose support), PeptiBal™ (gut health and world’s first A-biotic), AuroraBlue™ (wild Alaskan blueberry), MicroLactin® (joint health/sports recovery). For more information on Nutra Bridge, contact
[email protected].

1 Zenk J, Frestedt J, Kuskowski M. HUM5007, a Novel Combination of Thermogenic Compounds, and 3-acetyl-7-oxo-ehydroepiandrosterone: Each Increases the Resting Metabolic Rate of Overweight Adults. Journal of Nutritional Biochemistry 2007:18: 629-634
2 Kalman DS, Colker CM, Swain MA, Torina GC, Shi Q. A Randomized, Double-Blind, Placebo Controlled Study of 3-Acetyl-7-Oxo-
Dehydroepiandrosterone in Healthy Overweight Adults. Current Therapeutic Research 2000;61:435-442.
3 Zenk JL, Helmer TR, Kassen LJ, Kuskowski MA. The Effect of 7-Keto Naturalean on Weight Loss: A Randomized, Double-Blind, Placebo-Controlled Trial. Current Therapeutic Research 2002;63:263-272.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.